The first total synthesis of lajollamycin B, as tructurally novel nitro-tetraene spiro-b-lactone/g-lactonea ntibiotic, is described. The convergent synthesis involves the construction of the C8'-C11' nitrodienylstannane and its coupling with the segment prepared from the C1'-C7' w-iodo-heptadienoic acid and the right-hand heterocyclic fragment, which has been utilized for our previouss yntheses of oxazo-lomycinA.T he revisiono ft he geometry of the terminal D 10',11' -double bond from E to Z is also described for the structure of natural lajollamycin B.
The asymmetric total synthesis of (+)-marinomycin A, a 44-membered macrodiolide antitumor agent and antibiotic isolated from a marine actinomycete, Marinispora strain CNQ-140, is reported. The key features of the synthesis include the highly convergent stereocontrolled construction of the monomeric hydroxy salicylate starting from asymmetric epoxidation of the σ-symmetrical dialkenyl carbinol, and an unprecedented direct dimerization through NaHMDS-promoted double transesterification.
The asymmetric total synthesis of (+)-marinomycin A, a 44-membered macrodiolide antitumor agent and antibiotic isolated from a marine actinomycete, Marinispora strain CNQ-140, is reported. The key features of the synthesis include the highly convergent stereocontrolled construction of the monomeric hydroxy salicylate starting from asymmetric epoxidation of the s-symmetrical dialkenyl carbinol, and an unprecedented direct dimerization through NaHMDS-promoted double transesterification.
Total Synthesis of Marinomycin A Based on a Direct Dimerization Strategy. -(NISHIMARU, T.; KONDO, M.; TAKESHITA, K.; TAKAHASHI, K.; ISHIHARA, J.; HATAKEYAMA*, S.; Angew. Chem., Int. Ed. 53 (2014) 32, 8459-8462, http://dx.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.